Keywords: Sanofi-Aventis, Genzyme, EC approves merger, UCSF, Research, Cancer, Aging, Diabetes, Inflammation

Sanofi-Aventis gets EC approval for Genzyme bid; links with UCSF for early-stage research

Article | 13 January 2011

Print This

French drug major Sanofi-Aventis (Euronext: SAN) has cleared one hurdle in its quest to acquire US biotech firm Genzyme (Nasdaq: ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in